Category: News

Vaxxinova announces Chief Operating Officer (COO)

Nijmegen, the Netherlands – June 20, 2022 – We are pleased to announce the onboarding of Marcus Conradt as new COO at Vaxxinova, as of Monday June 20.Member of the Global Management Team, Marcus will be responsible for the coordination of production and R&D within Vaxxinova. Marcus is an experienced leader with proven management capabilities. […]
Read more →

Vaxxinova presents corporate movie

Nijmegen, NL – January 17, 2022 – Vaxxinova proudly presents its brand new corporate video. It gives an impression on our commitment to animal health, animal welfare and one health. Vaxxinova, we care.
Read more →

Vaxxinova Buys Newport Laboratories from Boehringer Ingelheim

Worthington, MN – Sept. 30, 2021 – Vaxxinova announced today that it has purchased Newport Laboratories, a company that manufactures custom-made vaccines for swine and cattle, from Boehringer Ingelheim. About 100 people work at Newport Laboratories in Worthington, Minnesota. They help veterinarians and livestock producers address animal health issues through diagnostic testing and production of […]
Read more →

Webinar Autogenous Vaccines on May 27th

May 6, 2021 – Cuxhaven, Germany On May 27th, 2021 at 4 PM CET Dr. Heike Bigmore, KAM with Vaxxinova Autogenous Vaccines GmbH,  will talk about the use of autogenous vaccines as a tool in disease control and mitigation of antimicrobial resistance (AMR) in animal production. The webinar, hosted by EW Nutrition, is titled Autogenous […]
Read more →

Vaxxinova US Announces USDA Approval of Vaxxon® SRP® Pasteurella

March 15, 2021 – Wilmar, MN, USA Vaxxinova US is announcing USDA approval of their new Vaxxon® SRP® Pasteurella vaccine.  Categorized by USDA as a Pasteurella Multocida Bacterial Extract, it is an effective, innovative and safe vaccine against fowl cholera in chickens.  Vaxxon SRP Pasteurella provides the industry a new category for long-term protection of […]
Read more →

Vaxxinova US gains market rights to SRP cattle vaccine from Zoetis

Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […]
Read more →

Vaxxinova invites you to IPPE 2020

Nijmegen, The Netherlands, Friday January 17, 2020. In January 2020, Vaxxinova will be present at the IPPE 2020 trade show in Atlanta. Our team is ready to meet you at booth C10361. The show is open to visitors on Tue Jan 28 (10 AM – 5 PM), Wed Jan 29 (9AM – 5PM), Thu Jan […]
Read more →

Biotech company Vaxxinova opens International Head Office and Research Laboratory at Novio Tech Campus in Nijmegen, the Netherlands

Press Release 30 June 2017 – Nijmegen, the Netherlands Vaxxinova, the new biotech company at Novio Tech Campus in Nijmegen, the Netherlands, celebrates the opening of their International Head Office and Research Laboratory with a festive inauguration ceremony on 30 June. Mayor of Nijmegen Hubert Bruls, Director Novio Tech Campus Rikus Wolbers and Vaxxinova’s CEO […]
Read more →